{"transactions":[{"id":3777358,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Restricted Stock Units","published_at":"2018-11-02T22:28:13.000Z","date":"2018-10-31","kind":"exercise","acquired":false,"shares":39625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 10/31/2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 10/31/2018."}],"balance_after":279064,"derivative":{"underlying":"Common Stock","underlying_shares":39625},"source":{"system":"sec-edgar","filing":"0001683168-18-003227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818003227/ownership.xml","form_type":"4"}},{"id":3777357,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Common Stock","published_at":"2018-11-02T22:28:13.000Z","date":"2018-10-31","kind":"exercise","acquired":true,"shares":18683,"price":1.04,"value":19430.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above."}],"balance_after":212370,"source":{"system":"sec-edgar","filing":"0001683168-18-003227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818003227/ownership.xml","form_type":"4"}},{"id":3857207,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Restricted Stock Units","published_at":"2018-08-01T14:33:26.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":39625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 7/31/2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 7/31/2018."}],"balance_after":318689,"derivative":{"underlying":"Common Stock","underlying_shares":39625},"source":{"system":"sec-edgar","filing":"0001683168-18-002088","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818002088/ownership.xml","form_type":"4"}},{"id":3857206,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Common Stock","published_at":"2018-08-01T14:33:26.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":18683,"price":1.23,"value":22980.09,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above."}],"balance_after":193687,"source":{"system":"sec-edgar","filing":"0001683168-18-002088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818002088/ownership.xml","form_type":"4"}},{"id":3950307,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Secretary"}}],"security":"Restricted Stock Units","published_at":"2018-05-03T01:07:21.000Z","date":"2018-04-30","kind":"exercise","acquired":false,"shares":39625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of April 30, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of April 30, 2018."}],"balance_after":358314,"derivative":{"underlying":"Common Stock","underlying_shares":39625},"source":{"system":"sec-edgar","filing":"0001683168-18-001166","document":"joyce_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818001166/joyce_frm4.xml","form_type":"4"}},{"id":3950306,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Secretary"}}],"security":"Common Stock","published_at":"2018-05-03T01:07:21.000Z","date":"2018-04-30","kind":"exercise","acquired":true,"shares":18771,"price":1.34,"value":25153.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above."}],"balance_after":175004,"source":{"system":"sec-edgar","filing":"0001683168-18-001166","document":"joyce_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818001166/joyce_frm4.xml","form_type":"4"}},{"id":4080233,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Secretary"}}],"security":"Restricted Stock Units","published_at":"2018-02-03T01:32:09.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":39625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of January 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of January 31, 2018."}],"balance_after":397939,"derivative":{"underlying":"Common Stock","underlying_shares":39625},"source":{"system":"sec-edgar","filing":"0001683168-18-000294","document":"joyce_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818000294/joyce_frm4.xml","form_type":"4"}},{"id":4080232,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Secretary"}}],"security":"Common Stock","published_at":"2018-02-03T01:32:09.000Z","date":"2018-01-31","kind":"exercise","acquired":true,"shares":16979,"price":1.5,"value":25468.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above."}],"balance_after":156233,"source":{"system":"sec-edgar","filing":"0001683168-18-000294","document":"joyce_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818000294/joyce_frm4.xml","form_type":"4"}},{"id":4108956,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Common Stock","published_at":"2018-01-04T20:40:02.000Z","date":"2017-12-29","kind":"gift","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Gift of 16,000 shares to immediate family members."}],"balance_after":139254,"source":{"system":"sec-edgar","filing":"0001683168-18-000046","document":"joyce_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818000046/joyce_frm4.xml","form_type":"4"}},{"id":4173663,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Restricted Stock Units","published_at":"2017-11-03T14:31:14.000Z","date":"2017-10-30","kind":"exercise","acquired":false,"shares":39625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of October 30, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of October 30, 2017."}],"balance_after":437564,"derivative":{"underlying":"Common Stock","underlying_shares":39625},"source":{"system":"sec-edgar","filing":"0001683168-17-002824","document":"joyce_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316817002824/joyce_frm4.xml","form_type":"4"}},{"id":4173662,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Common Stock","published_at":"2017-11-03T14:31:14.000Z","date":"2017-10-30","kind":"exercise","acquired":true,"shares":19079,"price":0.98,"value":18697.42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above."}],"balance_after":155254,"source":{"system":"sec-edgar","filing":"0001683168-17-002824","document":"joyce_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316817002824/joyce_frm4.xml","form_type":"4"}},{"id":4187078,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Restricted Stock Units","published_at":"2017-10-13T15:51:51.000Z","date":"2017-10-11","kind":"exercise","acquired":false,"shares":39625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of October 11, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of October 11, 2017."}],"balance_after":477189,"derivative":{"underlying":"Common Stock","underlying_shares":39625},"source":{"system":"sec-edgar","filing":"0001683168-17-002650","document":"joyce_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316817002650/joyce_frm4.xml","form_type":"4"}},{"id":4187077,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Common Stock","published_at":"2017-10-13T15:51:51.000Z","date":"2017-10-11","kind":"exercise","acquired":true,"shares":19079,"price":1.14,"value":21750.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above."}],"balance_after":136175,"source":{"system":"sec-edgar","filing":"0001683168-17-002650","document":"joyce_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316817002650/joyce_frm4.xml","form_type":"4"}},{"id":4338934,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Restricted Stock Units","published_at":"2017-05-02T16:02:20.000Z","date":"2017-05-01","kind":"disposition_to_issuer","acquired":false,"shares":19079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17 Represents conversion of restricted stock units with common stock issued on May 1, 2017 (with an effective date of April 28, 2017)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17 Represents conversion of restricted stock units with common stock issued on May 1, 2017 (with an effective date of April 28, 2017)."}],"balance_after":516814,"derivative":{"underlying":"Common Stock","underlying_shares":19079},"source":{"system":"sec-edgar","filing":"0001683168-17-001075","document":"joyce_f4-050117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316817001075/joyce_f4-050117.xml","form_type":"4"}},{"id":4338933,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Common Stock","published_at":"2017-05-02T16:02:20.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":19079,"price":2.23,"value":42546.17,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above."}],"balance_after":117096,"source":{"system":"sec-edgar","filing":"0001683168-17-001075","document":"joyce_f4-050117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316817001075/joyce_f4-050117.xml","form_type":"4"}},{"id":4462516,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Restricted Stock Units","published_at":"2017-02-08T19:54:12.000Z","date":"2017-02-07","kind":"disposition_to_issuer","acquired":false,"shares":98107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17Represents conversion of restricted stock units with common stock issued on February 7, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17Represents conversion of restricted stock units with common stock issued on February 7, 2017."}],"balance_after":535893,"derivative":{"underlying":"Common Stock","underlying_shares":98107},"source":{"system":"sec-edgar","filing":"0001683168-17-000256","document":"joyce_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316817000256/joyce_f4.xml","form_type":"4"}},{"id":4462515,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":162654,"kind":"person","name":"Joyce James A","position":1,"cik":"0001318931","reported_name":"Joyce James A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO, Secretary"}}],"security":"Common Stock","published_at":"2017-02-08T19:54:12.000Z","date":"2017-02-07","kind":"exercise","acquired":true,"shares":98107,"price":4.28,"value":419897.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above."}],"balance_after":98107,"source":{"system":"sec-edgar","filing":"0001683168-17-000256","document":"joyce_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316817000256/joyce_f4.xml","form_type":"4"}}]}